Hitachi

The companies are aiming to develop and establish clinical operation for the assays in Japan, where Hitachi said there is growing demand for such tests.

PSS, which develops tools for the IVD space, will supply to Hitachi its nucleic acid isolation system, fully automated diagnostic instruments, and reagents.

Under the terms of the collaboration, the firms will combine ZS Genetics' proprietary technologies with HTA's experience in high-resolution electron microscopy.

Initial projects include developing new automation systems based on PCR and next-generation sequencing.

Du Pont has been awarded

NEW YORK (GenomeWeb) − One challenge developers of nanopore sequencing technologies have been facing is DNA passing through the pores too quickly to detect its sequence with single-base resolution.

NEW YORK (GenomeWeb) – Annai Systems said today that it is working with Hitachi Data Systems to provide an integrated data management and analysis system that combines Hitachi's high-performance compute and cloud-based solutions and the Annai-GNOS data management software platform.

Title: Method for reconstructing evolutionary data
US Patent Number: 8,645,074
Assignee: International Business Machines

Title: Methods and compositions for base calling nucleic acids
US Patent Number: 8,612,161

NEW YORK (GenomeWeb News) – A group of bioinformatics and technology-focused firms and institutes that challenges informatics researchers to solve specific problems, has issued a new challenge to spur investigators to develop better methods for identifying cancer-associated mutations.

Pages

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.